LEVEL Act

HR 6228/S 593 The Ban Poisonous Additives Act of 2009: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) S 753 The Children's Safe Chemical Act: a ban on food contact materials for children and infants (3 years and under); (All provisions and amendments pertaining to the ban and the testing are relevant.) HR 4341 Bisphenol-A Consumer Information Act 2009: A bill to amend the Food, Drug and Cosmetic Act to require a warning on the label of any food container that is composed, in whole or in part, of Bisphenol-A or could release Bisphenol-A into the food; (All provisions relating to the science, restricitons on use and applications of Bisphenol-A in food applications.) HR 2749 Food Safety Enhancement Act of 2009, a reform of the law on food safety protection; (All provisions pertaining to the FDA mandate to make a safety determination on BPA before the end of the year.) S 510 Food Safety Modernization Act: A bill to modernize the Food and Drug Administration's regulation of food safety; (All provisions related to adding an amendment on Bisphenol-A.) HR 1332 Safe FEAST Act of 2009: A bill to empower the Food and Drug Administration to more thoroughly protect the food supply.) S 510 Food Safety and Modernization Act; (All sections.)

Client expense: $934,670 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 1549/S 619 To amend the Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (Title II General provisions in the bill.) HR 2749 Food Safety Enhancement Act of 2009 to amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food in the global market, and for other purposes; (Title 1 Food Safety. Monitoring food safety provisions.) HR 2400 Strategies to Address Antimicrobial Resistance; (Section 3(c) relating to authorities over Antimicrobial drug data collection.) HR 3519/S 1709 Veterinary Services Investment Act; (Support legislation.) HR 6228/S 593 The Ban Poisonous Additives Act of 2009: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) S 753 The Children's Safe Chemical Act: A ban on food contact materials for children and infants (3 years and under); (All provisions and amendments pertaining to the ban and the testing are relevant.) HR 4341 Bisphenol-A Consumer Information Act 2009: A bill to amend the Food Drug and Cosmetic Act to require a warning on the label of any food container that is composed, in whole or in part of Bisphenol-A or could release Bisphenol-a into the food; (All provisions relating to the science, restrictions on use and applications of Bisphenol-A in food applications.) HR 2749 Food Safety Enhancement Act of 2009, a reform of the law on food safety protection; (All provisions pertaining to the FDA mandate to make a safety determination on BPA before the end of the year.) HR 3962 Affordable Health Care for America Act; (Provisions related to subtitle, A,B,C, and D.) HR 4213 "American Jobs and Closing Tax Loopholes Act of 2010" (Sections pertaining to AMP, and allocation systems; all provisions related to pharmaceuticals and medical devices) S.Amdt 4369 to HR 4213 In the Nature of a substitute; (Sections pertaining to AMP, and allocation systems.) HR 1427 Promoting Innovation and Access to Life-Saving Medicine Act; (All relating to follow on biologics.) S 1142 the "Informed Health Care Decisions Making Act of 2009; (sections pertaining to comparative effectiveness.) HR 1321 Healthy Americans Act; (Relating to Medicare) HR 3590 Patient Protection and Affordable Care Act; (Sections relating to health insurance and drugs; All provisions relating to healthcare.) HR 3962 Affordable Health Care for America Act; (Sections relating to health insurance and drugs; All provisions related to pharmaceuticals and medical devices.) HR 4899 Making Emergency Supplemental Appropriations for Fiscal Year 2010; (All provisions related to pharmaceuticals and medical devices.)

HR 6228/S 593 the Ban Poisonous act of 2009, a bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) S 753 The Children's Safe Chemical Act, a ban on food contact materials for children and infants (3 years and under); (All provisions and amendments pertaining to the ban and the testing are relevant.) HR 4341 Bisphenol-A Consumer Information Act 2009, a bill to amend the Food, Drug, and Cosmetic Act to require a warning on the lable of any food container that is composed, in whole or in part, of Bisphenol-A or could release Bisphenol-A into the food; (All provisions relating to the science, restrictions on use and applications of Bisphenol-A in food applications.) HR 2749 Food Safety Enhancement Act of 2009, a reform of the law on food safety protection; (All provisions pertaining to the FDA mandate to make a safety determination on BPA before the end of the year.) HR 1549/S 619 To amend the Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal disease; (Title II. General provisions in the bill.) HR 2749 Food Safety Enhancement Act of 2009 To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food in the global market, and for other puposes; (Title I food Safety,; Monitoring food safety provisions.) HR 2400 Strategies to Address Antimicrobial Resistance; (Section 3 (c) relating to authorities over antimicrobial drug data collection.) HR 3519/S 1709 Veterninary Services Investment Act; (Support of legislation.) HR 1427 Promoting Innovation and Access to Life-Saving Medicine Act; (all relating to follow-on biologics.) S 1142 The "Informed Health Care Decision Making" Act of 2009; (Sections pertaining to comparative effectiveness.) HR 1321 Healthy Americans Act; (Relating to Medicare) Senate Finance Committee Chairman's Mark, America's Healthy Future Act of 2009 (All provisions.) HR 3590 Patient Protection and Affordable Care Act; (Sections relating to health insurance and drugs, all provsions relating to healthcare.) HR 3962 Affordable Health Care for America Act; (Sections relating to health insurance and drugs; provisions related to subtitles A, B, C, and D.) HR 4872 The Health Care and Education Afforability Reconciliation Act; (All provisions dealing with phramaceuticals and medical devices.) S 1796 America's Healthy Future Act of 2009; (Provisions relating to medical device excise tax, medicare reimbursement rates for medical imaging, comparative effectiveness research.) S 1679 Affordable Health Choices Act; (Provsions relating to medical device excise tax, medicare reimbursement rates for medical imaging, comparative effectiveness research.) HR 3200 America's Affordable Health Choices Act of 2009; (Provisions relating to medical device excise tax, medicare reimbursement rates for medical imaging, comparative effectiveness research.)

HR 6228/S 593 The Ban Poisonous Act of 2009, a bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) S 753 The Children's Safe Chemical Act, a ban on food contact materials for children and infants (3 years and under); (All provisions and amendments pertaining to the ban and the testing are relevant.) HR 4341 Bisphenol-A consumer Information Act 2009, a bill to amend the Food, Drug, and Cosmetic Act to require a warning on the label of any food container that is composed, in whole or in part, of Bisphenol-A or could release Bisphenol-A into the food; (All provisions relating to the science, restrictions on use and applications of Bisphenol-A in food applications.) HR 2749 Food Safety Enhancement Act of 2009, a reform of the law on food safety protection; (All provisions pertaining to the FDA mandate to make a safety determination on BPA before the end of the year.) S 510 Food Safety Modernization Act, a bill to modernize the Food and Drug Administrations regulation of food safety; (All provisions related to adding an amendment on Bisphenol-A.) HR 1332 Safe FEAST Act of 2009, a bill to empower the Food and Drug Administration to more thoroughly protect the food supply; (All provisions relating to BPA.) S 510 Food Safety and Modernization Act; (All sections.)

Client expense: $1,198,200 · Firm income: Not reported

HR 6228/S 593 the Ban Poisonous Act of 2009 A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) S 753 The Children's Safe Chemical Act a ban on food contact materials for children and infants (3 years and under); (All provisions and amendments pertaining to the ban and the testing are relevant.) HR 4341 Bisphenol-A Consumer Information Act of 2009, a bill to amend the Food Drug and Cosmetic Act to require a warning on the label of any food container that is composed, in whole or in part, of Bisphenol-A or could release Bisphenol A into the food; (All provisions relating to the science, restrictions on use and applications of Bisphenol-A in food applications.) HR 2749 Food Safety Enhancement Act of 2009, a reform of the law on food safety protection; (All provisions pertaining to the FDA mandate to make a safety determination on BPA before the end of the year.) S 510 Food Safety Modernization Act; (Provisions relating to all sections, provisions relating to strategy for comments.)

Client expense: $1,570,000 · Firm income: Not reported

HR 6228/S 593 The Ban Poisonous Act of 2009, A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (all provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) S 753 The Children's Safe Chemical Act a ban on food contact materials for children and infants (3 years and under); (All provisions and amendments pertaining to the ban and the testing are relevant.) HR 4341 Bisphenol -A Consumer Information Act of 2009, a bill to amend the Food Drug and Cosmetic Act to require a warning on the label of any food container that is composed, in whole or in part, of Bisphenol-A or could release Bisphenol A into the food; (All provisions relating to the science, restrictions on use and applications of Bisphenol-A in food applications.) HR 2749 Food Safety Enhancement Act of 2009, a reform of the law on food safety protection; (All provisions pertaining to the FDA mandate to make a safety determination on BPA before the end of the year.) HR 1427 Promoting Innovation and Access to Life-Saving Medicine Act; (All provisions relating to follow on biologics.) S 1142 The "Informed Health Care Decisions Making Act of 2009; (Sections pertaining to comparative effectiveness.) HR 1321 Healty Americans Act; (Provisions relating to Medicare.) Senate Finance Committee Chairman's Mark, America's Healthy Future Act of 2009; (All provisions.) HR 3590 Patient Protection and Affordable Care Act; (Sections relating to health insurance and drugs, all provisions relating to healthcare) HR 3962 Affordable Health Care for America Act; (Sections relating to health insurance and drugs, provisions related to subtitles A,B, C and D.) Senate: Patient Protection & Affordable Care Act; (All provisions relating to health care.) S 1796 America's Healthy Future Act of 2009; (Provisions relating to medical device excise tax, medicare reimbursement rates for medical imaging, comparative effectiveness research.) S 1679 Affordable Health Choices Act; (Provisions relating to medical device excise tax, medicare reimbursement rates for medical imaging, comparative effectiveness research.) HR 3200 America's Affordable Health Choices Act of 2009; (Provisions relating to medical device excise tax, medicare reimbursement rates for medical imaging, comparative effectiveness research.) HR 1549/S 619 the Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (Title II. General provisons in the bill.) HR 2749 Food Safety Enhancement Act of 2009 To amend the Federal Food, Drug, and cosmetic act to improve the safety of food in the global market, and for other purposes.) HR 3519/S 1709 Veterinary Services Investment Act (Support for legislation.) HR 2400 Strategies to Address Antimicrobial Resistance; (Section 3(c) relating to authorities over antimicrobial drug data collection.) S 510 Food Safety Modernization Act; (Provisions relating to strategy for comments.)

National Nanotechnology Initiative Amendments Act of 2009 (H.R. 554) National Nanotechnology Initiative Amendments Act of 2008 S.3274 Ban Poisonous Additives Act of 2009 - S. 593 // H.R. 1523 BPA Act - HR 6228

Client expense: $28,781 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Maritime Administration (MARAD), SENATE

H.R. 6228/S. 593 The Ban Poisonous Additivies of 2009; (All provisions pertaining to the ban of food contact applications and the science used to support the ban of products containing Bisphenol-A.) S. 753 The Children's Safe Chemical Act, a ban on food contact materials for children and infants (3 years and under); (All provisions and amendments pertaining to the ban on testing.)

Client expense: $1,843,672 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Legislation from the 110th HR 6228, the Ban Poisonous Additives Act (no Senate version). This bill would ban the chemical bisphenal-A from all food and beverage containers. Continued: Legislation from the 110th HR 6228, the Ban Poisonous Additives Act (no Senate version) The Breast Cancer Fund supports this legislation because bisphenal-A has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund has been meeting with staff from various offices to explore revisions to H.R. 6228 in anticipation of the introduction of similar legislation in the 111th Congress. HR 5809, the Environmental Hormone Disruption Act (no Senate version) This bill would authorize the director of the National Institute of Environmental Health Sciences (NIEHS) to establish a comprehensive program to better understand the impact of hormone disrupting pollutants in the environment on the health of women and children. The Breast Cancer Fund supports this legislation because of the need for more research on the links between environmental hazards and health. The Breast Cancer Fund has been meeting with staff of the principal author Congresswoman Slaughter to re-draft the bill in anticipation of the introduction of a version of the bill in the 111th Congress. Future Legislative Proposals The Breast Cancer Fund has met with staff from the Senate HELP Committee to discuss future legislation for a second War on Cancer. The Breast Cancer Fund has provided counsel on sections of the bill pertaining to cancer and the environment. The Breast Cancer Fund has also met with staff from various House offices to draft legislation to reform the FDAs regulation of cosmetic ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. Regulation and Legislative Intent P.L. 110-314 The Consumer Product Safety Commission Improvement Act This law has broadly reformed and modernized the Consumer Product Safety Commission. The Breast Cancer Fund lobbied in support of a Feinstein amendment, which inserts phthalates as a banned substance in the manufacture of childrens toys. We are now working with legislative conferees and their staff to insure effective regulatory implementation of the bill by the Consumer Product Safety Commission including submission of public comment and investigation of specific determinations by the CPSCs legislation counsel regarding specific sections of the law. P.L. 110-354 -- Breast Cancer and Environmental Research Act of 2008 This law authorizes the Director of the National Institute of Environmental Health Sciences to make grants for the development and operation of research centers regarding environmental factors that may be related to the etiology of breast cancer. The Breast Cancer Fund was not actively involved in passage of the bill apart from coalition support but has since met with authors to discuss implementation and the appointment process to the community panel that will oversee the grant process. H.R.962 Preservation of Antibiotics for Medical Treatment Act Sponsor: Rep Slaughter, Louise McIntosh Title: To amend the Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases. H.R.6432 Animal Drug User Fee Sponsor: Rep Pallone, Frank, Jr. Title: To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the animal drug user fee program, and for other purposes. H.R.6100 Kid-Safe Chemicals Act Sponsor: Rep Solis, Hilda L. Title: To amend the Toxic Substances Control Act to reduce the exposure of children, workers, and consumers to toxic chemical substances. S.3040 Kid-Safe Chemicals Act Sponsor: Sen Lautenberg, Frank R. Title: A bill to amend the Toxic Substances Control Act to reduce the exposure of children, workers, and consumers to toxic chemical substances. H.R.398 Healthy Places Act Sponsor: Rep Solis, Hilda L. Title: To require Federal agencies to support health impact assessments and take other actions to improve health and the environmental quality of communities, and for other purposes. H.R.1103 Environmental Justice Act Sponsor: Rep Solis, Hilda L. Title: To codify Executive Order 12898, relating to environmental justice, to require the Administrator of the Environmental Protection Agency to fully implement the recommendations of the Inspector General of the Agency and the Comptroller General of the United States, and for other purposes.